Shionogi & Co., Ltd. is a leading pharmaceutical company based in Japan. With a medium risk rating score of 23.1, Shionogi specializes in the manufacturing and distribution of specialty and generic drugs, diagnostic reagents, and medical devices. Their research and development strategy focuses on partnerships and licensing opportunities with academic and venture companies. The company is committed to ESG principles in its manufacturing, formulation, packaging, and analysis processes.